A detailed history of Hixon Zuercher, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hixon Zuercher, LLC holds 2,852 shares of ABBV stock, worth $493,453. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,852
Previous 2,850 0.07%
Holding current value
$493,453
Previous $488,000 15.37%
% of portfolio
0.22%
Previous 0.21%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.07%
2,852 $563,000
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $31,964 - $36,420
-200 Reduced 6.56%
2,850 $518,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $34,400 - $38,742
250 Added 8.93%
3,050 $472,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $28,922 - $33,308
200 Added 7.69%
2,800 $446,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $21,280 - $24,156
200 Added 8.33%
2,600 $280,000
Q2 2020

Oct 13, 2021

BUY
$73.37 - $98.18 $176,088 - $235,632
2,400 New
2,400 $236,000
Q1 2020

Oct 13, 2021

SELL
$64.5 - $97.79 $154,800 - $234,696
-2,400 Closed
0 $0
Q4 2019

Oct 13, 2021

BUY
$72.13 - $90.25 $173,112 - $216,600
2,400 New
2,400 $212,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hixon Zuercher, LLC Portfolio

Follow Hixon Zuercher, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hixon Zuercher, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hixon Zuercher, LLC with notifications on news.